CeriBell, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| CeriBell, Inc. | CBLL - NASDAQ |
$14.00-$16.00 | $17.00 | $23.26 | 10.6 million | 10/11/2024 |
| BofA Securities, J.P. Morgan | ||||||
Co-Manager(s): William Blair, TD Cowen, Canaccord Genuity | ||||||
| Health Care | ||||||
Filing(s): Filed 2024-08-26 Terms Added 2024-10-07 Amended Prospectus 2024-10-09 | ||||||
CeriBell, Inc. Quote & Chart - Click for current quote - CBLL
IPO Boutique aggregates information on public companies and private companies, such as "CBLL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About CeriBell, Inc. (adapted from CeriBell, Inc. prospectus):
They are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CBLL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.